Use of elevated insulin-like growth factor binding protein-1 (IGFBP-1) to predict outcomes in men with metastatic prostate cancer treated with androgen-deprivation therapy (ADT).
Jaya Sharma
No relevant relationships to disclose
Kathryn P. Gray
No relevant relationships to disclose
Mari Nakabayashi
No relevant relationships to disclose
Gillian Petrozziello
No relevant relationships to disclose
Carolyn Evan
No relevant relationships to disclose
Raina Fichorova
No relevant relationships to disclose
Philip W. Kantoff
No relevant relationships to disclose
Christopher Sweeney
No relevant relationships to disclose